A COMPOSITION FOR REDUCING LUNG AND/OR SYSTEMIC INFLAMMATION ASSOCIATED WITH PM2.5 EXPOSURE AND THE USE THEREOF

摘要

Provided is a composition for reducing lung and/or systemic inflammation associated with PM2.5 exposure, comprising docosahexanoic acid, a probiotic strain(such as Bifidobacterium animalis subsp. Lactis), Vitamin C and Vitamin E. Also provided is the use of this composition for human subjects living in the environment with the average daily level of PM2.5 between 25 and 500 μg/m 3, especially between 100 and 500 μg/m 3.